BBramley
TL3 Regular · Strasbourg, FR
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 28 December 2024 · last posted just now
145 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #48 · Clinical › Bloodwork · 28 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #23 · Clinical › Bloodwork · 27 Jul 2026 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #85 · Practice › Dosing & titration · 21 Jul 2026 · 29 likes post #84 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Common supplements people ask about, assessed one at a time Replied, post #73 · Practice › Interactions · 20 Jul 2026 · 28 likes This follows post #70 rather than contradicting it. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #52 · Clinical › Prescriber conversations · 19 Jul 2026 · 18 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
Journal club: what we got wrong in an earlier session Replied, post #97 · Evidence › Journal club · 18 Jul 2026 · 0 likes I read post #95 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #111 · Devices › Syringes & needles · 18 Jul 2026 · 13 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #85 · Meta › Announcements · 18 Jul 2026 · 8 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #71 · Compounds › Retatrutide · 18 Jul 2026 · 3 likes Coming back to post #69, because the follow-up matters more than the original answer. Triple agonism: is the effect additive, synergistic, or neither? A phase 2…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #29 · Practice › Interactions · 15 Jul 2026 · 29 likes On post #25 — agreed on the reasoning, with one qualification. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
-
Pooling trials with different estimands Replied, post #99 · Evidence › Meta-analyses · 15 Jul 2026 · 5 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #15 · Access › Insurance & coverage · 10 Jul 2026 · 3 likes I read post #13 twice before replying, because I had assumed the opposite. Tier placement and step therapy: some formularies place a medication on a higher tier or…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #9 · Practice › Interactions · 9 Jul 2026 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Tracking a shortage from primary sources rather than rumour Replied, post #92 · Access › Shortages · 9 Jul 2026 · 10 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Restarting after a long gap: what the labelling implies Replied, post #16 · Practice › Dosing & titration · 8 Jul 2026 · 0 likes This follows post #13 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Prescription requirements and telehealth models — a second dataset Replied, post #95 · Sourcing › Regulatory · 7 Jul 2026 · 2 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #54 · Compounds › Repair & healing peptides · 5 Jul 2026 · 1 like post #53 is right about the mechanism and I think understates the practical bit. What would change the position on repair peptides: adequately powered, published,…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #22 · Evidence › Journal club · 4 Jul 2026 · 11 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Prescription portability between countries Replied, post #79 · Access › International · 28 Jun 2026 · 0 likes post #78 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #33 · Outcomes › Body composition · 27 Jun 2026 · 26 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #85 · Safety › Contraindications · 24 Jun 2026 · 8 likes post #84 is right about the mechanism and I think understates the practical bit. Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #15 · Pharmacology › Receptor biology · 11 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Packaging that arrived damaged: documenting it properly Replied, post #21 · Sourcing › Logistics · 7 Jun 2026 · 0 likes Worth separating two things that post #17 runs together. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #36 · Evidence › Journal club · 7 Jun 2026 · 6 likes This follows post #33 rather than contradicting it. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question?…
-
Reading a trial's population section before its results Replied, post #95 · Evidence › Trials · 6 Jun 2026 · 12 likes Worth separating two things that post #91 runs together. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses…
-
Forced degradation studies: designing one that is informative Replied, post #70 · Analytics › Method validation · 5 Jun 2026 · 9 likes Coming back to post #68, because the follow-up matters more than the original answer. Stability-indicating method: one that can separate a compound from its degradation…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #20 · Pharmacology › Pharmacokinetics · 31 May 2026 · 9 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #4 · Evidence › Meta-analyses · 6 May 2026 · 6 likes I read post #2 twice before replying, because I had assumed the opposite. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator,…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #23 · Compounds › Tirzepatide · 5 May 2026 · 27 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #130 · Pharmacology › Pharmacokinetics · 5 May 2026 · 2 likes This follows post #127 rather than contradicting it. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the…
-
A fridge failure and how I assessed the contents afterwards Replied, post #9 · Devices › Cold chain · 2 May 2026 · 0 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
-
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #10 · Pharmacology › Receptor biology · 17 Apr 2026 · 0 likes This follows post #7 rather than contradicting it. Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #26 · Practice › Interactions · 14 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: State-level differences that actually matter Replied, post #91 · Regional › North America · 8 Apr 2026 · 13 likes Picking up post #88: that is the part I would want checked first. Regional variation in North America: access differs substantially by US state and Canadian province.…
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #12 · Pharmacology › Formulation chemistry · 5 Apr 2026 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Amino acid residues and formulation: the specific sequence and composition of a peptide affects what…
-
Journal club: is percentage weight change the right endpoint? Replied, post #39 · Evidence › Journal club · 4 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The "under review" status pill and when a moderator applies it Replied, post #52 · Evidence › Preprints · 3 Apr 2026 · 15 likes This follows post #49 rather than contradicting it. Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite…
-
Preprint servers and what screening they do Replied, post #101 · Evidence › Preprints · 24 Mar 2026 · 30 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #11 · Analytics › Mass spectrometry · 22 Mar 2026 · 6 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #58 · Practice › Interactions · 21 Mar 2026 · 5 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #130 · Practice › Interactions · 11 Mar 2026 · 22 likes Picking up post #127: that is the part I would want checked first. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #69 · Clinical › Special populations · 11 Mar 2026 · 31 likes Picking up post #66: that is the part I would want checked first. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #2 · Analytics › Mass spectrometry · 10 Mar 2026 · 2 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #4 · Evidence › Journal club · 7 Mar 2026 · 2 likes post #2 answers the question as asked. The question underneath it is different. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to…
-
Validating a calculator against hand arithmetic Replied, post #9 · marked as the solution · Data & Tools › Calculators · 3 Mar 2026 · 7 likes Worth separating two things that post #5 runs together. Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #139 · Analytics › COA interpretation · 24 Feb 2026 · 3 likes On post #135 — agreed on the reasoning, with one qualification. What fields matter on a certificate: lot number matching the vial, test date, the analytical method…
-
MHRA statements, read directly Replied, post #92 · Regional › UK & Ireland · 19 Feb 2026 · 0 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #23 · Practice › Dosing & titration · 16 Feb 2026 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Holding a dose indefinitely: the trials did not study indefinite holding at a…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #84 · Documentation › Wiki requests · 12 Feb 2026 · 17 likes post #83 answers the question as asked. The question underneath it is different. Translation suggestions: if a maintained page should exist in another language,…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #18 · Practice › Administration · 8 Feb 2026 · 0 likes On post #14 — agreed on the reasoning, with one qualification. A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days…
-
Reading an interaction checker output critically Replied, post #113 · Practice › Interactions · 7 Feb 2026 · 22 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #21 · Practice › Reconstitution · 30 Jan 2026 · 12 likes Coming back to post #19, because the follow-up matters more than the original answer. Osmolarity and reconstitution: the osmolarity of the reconstituted solution…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #27 · Pharmacology › Pharmacokinetics · 29 Jan 2026 · 0 likes post #26 answers the question as asked. The question underneath it is different. Individual variation: people vary in how quickly they absorb, distribute, metabolise,…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #64 · Access › Pricing · 17 Jan 2026 · 15 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
-
Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold? Replied, post #2 · Evidence › Journal club · 2 Jan 2026 · 28 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #51 · Compounds › Semaglutide · 2 Jan 2026 · 12 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #31 · Access › International · 29 Dec 2025 · 10 likes On post #27 — agreed on the reasoning, with one qualification. Import rules for personal use: what you can import for personal use depends on your country's rules, not…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #3 · Practice › Administration · 24 Dec 2025 · 25 likes Worth separating two things that the opening post runs together. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 24 Dec 2025 · 0 likes Worth separating two things that post #13 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #36 · Analytics › Method validation · 24 Dec 2025 · 31 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Meeting a protein target on a suppressed appetite Replied, post #42 · Nutrition & Training › Protein & intake · 14 Dec 2025 · 13 likes Picking up post #39: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #36 · Pharmacology › Pharmacokinetics · 12 Dec 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #52 · Compounds › Tirzepatide · 7 Dec 2025 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Tracking a preprint to publication: a worked example Replied, post #58 · Evidence › Preprints · 6 Dec 2025 · 0 likes I read post #56 twice before replying, because I had assumed the opposite. How to cite a preprint: author last name, first initial, et al. Title. Server name…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #60 · Practice › Reconstitution · 25 Nov 2025 · 9 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #38 · Analytics › Impurities & related substances · 21 Nov 2025 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #47 · Compounds › Semaglutide · 14 Nov 2025 · 33 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Follow-up: Why appetite effects are mostly central Replied, post #91 · Pharmacology › Receptor biology · 9 Nov 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #13 · Sourcing › Regulatory · 18 Oct 2025 · 20 likes post #12 answers the question as asked. The question underneath it is different. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug…
-
Sleep quality changes during weight loss — what changed since Replied, post #28 · Wellbeing › Sleep · 16 Oct 2025 · 13 likes This follows post #25 rather than contradicting it. Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #79 · Practice › Reconstitution · 15 Oct 2025 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
What a purity-only report leaves out Replied, post #47 · Sourcing › Independent verification · 15 Oct 2025 · 0 likes This follows post #44 rather than contradicting it. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has…
-
New subcategory: rationale and scope Replied, post #16 · Meta › Announcements · 13 Oct 2025 · 13 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #102 · Analytics › HPLC & UHPLC · 10 Oct 2025 · 32 likes post #101 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #137 · Practice › Reconstitution · 3 Oct 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #148 · Practice › Storage & stability · 23 Sep 2025 · 4 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #27 · Data & Tools › Datasets · 7 Sep 2025 · 9 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #82 · Evidence › Journal club · 6 Sep 2025 · 21 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #67 · Evidence › Journal club · 1 Sep 2025 · 2 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
A ten-fold dose error caught before injection Replied, post #90 · Devices › Syringes & needles · 28 Aug 2025 · 18 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #12 · Analytics › Method validation · 23 Aug 2025 · 0 likes This follows post #9 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #2 · Compounds › Tirzepatide · 23 Aug 2025 · 0 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #118 · Compounds › Semaglutide · 13 Aug 2025 · 1 like The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #21 · Evidence › Journal club · 12 Aug 2025 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Travel coolers and how long they really hold Replied, post #73 · Devices › Cold chain · 7 Aug 2025 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
How to research a compound with no human data without deceiving yourself Replied, post #9 · Compounds › Other compounds · 30 Jul 2025 · 16 likes Picking up post #6: that is the part I would want checked first. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #14 · Analytics › Method validation · 21 Jul 2025 · 8 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2025 · 10 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Foaming during reconstitution and whether it matters Replied, post #19 · Practice › Reconstitution · 11 Jul 2025 · 25 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #19 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2025 · 20 likes Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #6 · marked as the solution · Start Here › Welcome · 25 Jun 2025 · 12 likes This follows post #3 rather than contradicting it. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is…
-
State-level differences that actually matter Replied, post #6 · Regional › North America · 22 Jun 2025 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Antibiotics and a course of something with delayed emptying Replied, post #68 · Practice › Interactions · 18 Jun 2025 · 9 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #64 · Access › Insurance & coverage · 11 Jun 2025 · 11 likes Worth separating two things that post #60 runs together. Documentation your clinician can provide: letters from clinicians describing why standard treatments have…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #33 · Evidence › Journal club · 10 Jun 2025 · 0 likes This follows post #30 rather than contradicting it. Session format: read the paper before posting. The discussion is much better when everyone has. Start with the…
-
Appeal templates and why they are deliberately unemotional Replied, post #4 · Access › Insurance & coverage · 7 Jun 2025 · 19 likes Coming back to the opening post, because the follow-up matters more than the original answer. Tier placement and step therapy: some formularies place a medication on a…
-
A report I filed that turned out to be wrong, and the correction Replied, post #72 · Sourcing › Vendor reports · 27 May 2025 · 0 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #156 · Sourcing › Regulatory · 19 May 2025 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Pregnancy as an absolute contraindication Replied, post #52 · Safety › Contraindications · 19 May 2025 · 0 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #44 · Outcomes › Body composition · 15 May 2025 · 9 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #56 · Data & Tools › Calculators · 8 May 2025 · 12 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #127 · Documentation › Doc review · 27 Apr 2025 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Dizziness on standing: the ordinary explanation first Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 26 Apr 2025 · 8 likes post #13 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Follow-up: What other technical communities get right that we do not Replied, post #74 · Lounge › Off topic · 21 Apr 2025 · 2 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #23 · Data & Tools › Calculators · 19 Apr 2025 · 3 likes post #22 answers the question as asked. The question underneath it is different. Storage lookup: which conditions (temperature, time) are you considering storing in,…
-
Sequence verification for an obscure compound: how it is done Replied, post #8 · Compounds › Other compounds · 8 Apr 2025 · 5 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Counter-ion content and its effect on measured mass Replied, post #12 · Analytics › Mass spectrometry · 6 Apr 2025 · 1 like post #11 answers the question as asked. The question underneath it is different. Desalting before analysis: some samples need desalting to remove salts that suppress…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #15 · Practice › Administration · 30 Mar 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Validating a method you did not develop — does this still hold? Replied, post #143 · Analytics › Method validation · 20 Mar 2025 · 14 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #100 · Analytics › COA interpretation · 19 Mar 2025 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #142 · Sourcing › Vendor reports · 19 Mar 2025 · 9 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #32 · Sourcing › Vendor reports · 15 Mar 2025 · 20 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #6 · Devices › Syringes & needles · 15 Mar 2025 · 17 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #99 · Compounds › Semaglutide · 13 Mar 2025 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #100 · Data & Tools › Calculators · 22 Feb 2025 · 5 likes Coming back to post #98, because the follow-up matters more than the original answer. Mass error checking: enter your observed mass and theoretical mass and check…
-
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #3 · Analytics › Impurities & related substances · 14 Feb 2025 · 4 likes Coming back to the opening post, because the follow-up matters more than the original answer. Aggregates: multiples of the monomer mass. May not elute at all under a…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #5 · Compounds › Semaglutide · 6 Feb 2025 · 14 likes This follows post #2 rather than contradicting it. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without…
-
A page that has drifted out of date and needs a maintainer Replied, post #59 · Documentation › Wiki requests · 2 Feb 2025 · 29 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion.
-
Scheduled maintenance and what will be unavailable Replied, post #22 · Meta › Announcements · 23 Jan 2025 · 7 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #17 · Practice › Reconstitution · 21 Jan 2025 · 18 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Isotonicity and what happens when you get it wrong Replied, post #28 · Pharmacology › Formulation chemistry · 14 Jan 2025 · 7 likes Coming back to post #26, because the follow-up matters more than the original answer. Preservatives: solutions for multi-dose vials contain preservatives (benzyl…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #36 · Compounds › Oral incretins · 10 Jan 2025 · 28 likes Coming back to post #34, because the follow-up matters more than the original answer. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #30 · Safety › Adverse events · 21 Dec 2024 · 0 likes post #29 answers the question as asked. The question underneath it is different. How to document: date, exact symptom or event, severity, duration, outcome, any medical…
-
Building a sensible monitoring schedule with your prescriber Replied, post #50 · Clinical › Bloodwork · 20 Dec 2024 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Coming back to: When to suspect the method rather than the sample Replied, post #99 · Analytics › Method validation · 19 Dec 2024 · 0 likes post #98 answers the question as asked. The question underneath it is different. Accuracy: the method measures what you intend to measure. For purity methods, this is…
-
Body image changing more slowly than the body Replied, post #24 · Wellbeing › Mental health · 13 Dec 2024 · 1 like post #23 is right about the mechanism and I think understates the practical bit. Body image and weight loss: large weight loss changes a person's relationship with…
-
What we do not know about retatrutide, listed explicitly Replied, post #17 · Compounds › Retatrutide · 10 Dec 2024 · 1 like post #16 is right about the mechanism and I think understates the practical bit. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple…
-
Washout with a one-week half-life: the arithmetic Replied, post #85 · Research Methods › N-of-1 designs · 7 Dec 2024 · 0 likes Worth separating two things that post #81 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Why "any advice?" is the least effective ending for a post Replied, post #64 · Start Here › How to Ask · 23 Nov 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
EMA product information as a primary source — does this still hold? Replied, post #146 · Regional › European Union · 19 Nov 2024 · 0 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #6 · Analytics › Mass spectrometry · 13 Nov 2024 · 8 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Time to steady state after a dose increase Replied, post #41 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 8 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
When "no data" is the complete and final answer Replied, post #10 · Compounds › Other compounds · 27 Oct 2024 · 0 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Second pass at: Reimbursement variation across member states Replied, post #23 · Regional › European Union · 23 Oct 2024 · 0 likes Picking up post #20: that is the part I would want checked first. Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular…
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #12 · Analytics › Impurities & related substances · 18 Oct 2024 · 11 likes post #11 answers the question as asked. The question underneath it is different. Off-target structures: if the sequence synthesis goes wrong, a completely different…
-
Blind submission and why it changes minds Replied, post #77 · Sourcing › Independent verification · 3 Oct 2024 · 2 likes This follows post #74 rather than contradicting it. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual…
-
Identical chromatograms across two different lots Replied, post #32 · Sourcing › Red flags · 3 Oct 2024 · 1 like Coming back to post #30, because the follow-up matters more than the original answer. Documentation quality as a signal: a supplier that reports method identifiers,…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #103 · Sourcing › Independent verification · 2 Oct 2024 · 7 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #36 · Evidence › Journal club · 6 Sep 2024 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Promotion criteria, and the one that stops most nominations Replied, post #51 · Documentation › Doc review · 1 Sep 2024 · 0 likes Picking up post #48: that is the part I would want checked first. Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page,…
-
Correlation in a self-tracked dataset: what it can support Replied, post #50 · Research Methods › Statistics · 22 Aug 2024 · 8 likes P-values and significance: p
-
Circumference measurements as a poor man's composition estimate Replied, post #67 · Outcomes › Body composition · 14 Aug 2024 · 0 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #96 · Practice › Dosing & titration · 9 Jul 2024 · 30 likes This follows post #93 rather than contradicting it. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but…
-
[2026 update] Comparing tirzepatide and semaglutide is harder than the tables suggest Started this topic · Compounds › Tirzepatide · 8 Jun 2024 · 11 likes Comparing tirzepatide and semaglutide is harder than the tables suggest Writing it up because I had to work it out twice and would rather nobody else did. Comparing…
-
Assessing a warm arrival: the decision process — one year on Replied, post #127 · Sourcing › Logistics · 2 Jun 2024 · 0 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…